Trials / Sponsors / MitoImmune Therapeutics
MitoImmune Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subje Heathly Subjects | Phase 1 | 2022-05-13 |
| Active Not Recruiting | Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT Oral Mucositis, Lymphoma, Multiple Myeloma | Phase 2 | 2022-02-01 |
| Active Not Recruiting | MIT-001 for Prevention of CCRT-Induced OM in HNSCC Patients Head and Neck Squamous Cell Carcinoma, Oral Mucositis | Phase 2 | 2021-06-21 |